Featured News
942Wire StoriesTakeda Oncology Demonstrates Leadership in Hematologic Cancers at 62nd American Society of Hematology (ASH) Annual Meeting
? Company to Present 22 Abstracts in Oncology, Including 5 Oral Presentations, Demonstrating Takeda’s Enduring Commitment to Improving the Lives of Patients...
- 768News
Explain Ninja is Leading the List of the Best Explainer Video Production Agencies in Poland for 2020
In October 2020, The Manifest published the list of The Best Video Production Companies. A Polish animation production agency, Explain Ninja, entered...
- 790Wire Stories
Visionstate Develops New Wanda Occupancy Measurement Feature to Address Covid-19 Social Distancing Protocols
EDMONTON, Alberta, Nov. 05, 2020 (GLOBE NEWSWIRE) — Visionstate Corp. (TSX-V: VIS) (“Visionstate”) is pleased to announce the addition of its new...
- 943Wire Stories
AM Best Revises Outlooks to Negative for Singapore Reinsurance Corporation Limited
SINGAPORE–(BUSINESS WIRE)–AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating of A- (Excellent) and the...
- 764Wire Stories
Indian Healthcare Sector – A Promising $353 Billion Opportunity by 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Indian e-Health – The ‘New Norm’ Post COVID” report has been added to ResearchAndMarkets.com’s offering. The Indian ‘eHealth’ sector is...
- 795Wire Stories
Andersen Global Enters Armenia
SAN FRANCISCO–(BUSINESS WIRE)–#agexpansion–Andersen Global initiates expansion in Armenia through a Collaboration Agreement with TK & Partners, a full-service law firm based in...
- 782Wire Stories
AM Best Places Credit Ratings of Lifetime Income Limited Under Review with Negative Implications
SINGAPORE–(BUSINESS WIRE)–AM Best has placed under review with negative implications the Financial Strength Rating of B (Fair) and the Long-Term Issuer Credit...
- 809Wire Stories
BeiGene Announces Data on BRUKINSA® (Zanubrutinib) and Tislelizumab to Be Presented at the 62nd ASH Annual Meeting
CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–$BGNE #ASH–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines...
- 789Wire Stories
Mirum Pharmaceuticals Broadens Expanded Access Program for Maralixibat in Alagille Syndrome to Europe and Australia
Maralixibat Expanded Access Program now available for patients with pruritus associated with Alagille syndrome in Australia and 10 countries in Europe. FOSTER...
- 780Wire Stories
InnoCare to Present Clinical Data of Orelabrutinib at the Upcoming 62nd Annual Meeting of ASH
BEIJING–(BUSINESS WIRE)–InnoCare Pharma (HKEX: 09969), a clinical-stage biopharmaceutical company, announced today that the company will present latest clinical data of its BTK...
- 883Wire Stories
Nov?lent Launches Patented US Technology in Australia & New Zealand Markets to Help Fight COVID-19
GREENSBORO, N.C.–(BUSINESS WIRE)–Nov?lent Biotech, Inc (‘Nov?lent’), a US biotechnology engineering firm, announces it is launching its patented surface disinfectant products in Australia...
